Long-term Equity-based Compensation - Option and SAR Activity (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares
Shares Subject to Awards
Outstanding at Beginning of the Year (in shares) | shares	2,325,576
Granted (in shares) | shares	239,026
Exercised (in shares) | shares	(50,297)
Forfeited or Expired (in shares) | shares	(140,986)
Outstanding at December 31, 2019 (in shares) | shares	2,373,319
Vested and Expected to Vest at December 31, 2019 (in shares) | shares	2,320,371
Exercisable at December 31, 2019 (in shares) | shares	1,801,418
Weighted- average Exercise Price Per Share ($)
Outstanding at Beginning of the Year (in dollars per share) | $ / shares	$ 59.10
Granted (in dollars per share) | $ / shares	58.19
Exercised (in dollars per share) | $ / shares	37.57
Forfeited or Expired (in dollars per share) | $ / shares	62.41
Outstanding at December 31, 2019 (in dollars per share) | $ / shares	59.27
Vested and Expected to Vest at December 31, 2019 (in dollars per share) | $ / shares	59.31
Exercisable at December 31, 2019 (in dollars per share) | $ / shares	$ 59.92
Weighted- average Remaining Contractual Life (in Years)
Outstanding at December 31, 2023	5 years 4 months 20 days
Vested and Expected to Vest at December 31, 2023	5 years 3 months 25 days
Exercisable at December 31, 2023	4 years 5 months 12 days
Aggregate Intrinsic Value ($ In Millions)
Outstanding at December 31, 2023 | $	$ 5.4
Vested and Expected to Vest at December 31, 2023 | $	5.4
Exercisable at December 31, 2023 | $	$ 5.4